![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » MERIDIAN ANNOUNCES 510K SUBMISSION TO THE FDA FOR THE LIPO-LASER
MERIDIAN ANNOUNCES 510K SUBMISSION TO THE FDA FOR THE LIPO-LASER
June 21, 2006
Meridian Co., Ltd. announced that it has reached a major milestone in the execution of its strategic business plan of establishing a significant role in the 9 billion dollar aesthetic market in North America. The company filed a Premarket Notification, or a 510(k) with the
US FDA, to allow it to market the non-invasive Lipo-Laser device for the indication
of body contouring and temporary reduction in the appearance of cellulite. Using
cutting edge laser technology intended specifically for this use, this device
will be the first of its kind that would be cleared by the US FDA.
Market
Wire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct